Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 16/20 | 0.48 |
| ▸ | PPARG | P37231 | 2/20 | 0.47 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.47 |
| ▸ | HNF4A | P41235 | 3/20 | 0.43 |
| ▸ | RARG | P13631 | 6/20 | 0.41 |
| ▸ | RARB | P10826 | 5/20 | 0.41 |
| ▸ | RARA | P10276 | 4/20 | 0.41 |
| ▸ | RXRB | P28702 | 2/20 | 0.41 |
| ▸ | RXRG | P48443 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6033001 | 0.92 | RXRA (0.50) | RXRAPPARGNR1H3HNF4ARARG | |
| SCHEMBL6033253 | 0.90 | RARA (0.41) | RXRAPPARGNR1H3HNF4ARARG | |
| SCHEMBL6032986 | 0.89 | RXRA (0.59) | RXRAPPARGNR1H3HNF4ARXRB | |
| SCHEMBL6033022 | 0.89 | RARA (0.52) | RXRAPPARGNR1H3HNF4ARARG | |
| SCHEMBL6033265 | 0.88 | RXRA (0.52) | RXRAPPARGNR1H3HNF4ARARG | |
| SCHEMBL6560072 | 0.87 | RXRA (0.50) | RXRAPPARGNR1H3HNF4ARARG | |
| SCHEMBL6562290 | 0.87 | RXRA (0.48) | RXRAPPARGNR1H3HNF4ARARG | |
| SCHEMBL6032656 | 0.86 | RXRA (0.61) | RXRAPPARGNR1H3HNF4ARARG | |
| SCHEMBL6033276 | 0.86 | RXRA (0.51) | RXRAPPARGNR1H3HNF4ARARG | |
| SCHEMBL6561458 | 0.84 | RXRA (0.40) | RXRAPPARGNR1H3HNF4ARARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1086080-B1 | DIARYLSELENIDE COMPOUNDS AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETICS | GALDERMA RES & DEV (FR) | 2004-08-25 | — | — | EP | claimed |
| EP-1086080-A1 | DIARYLSELENIDE COMPOUNDS AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETICS | Galderma Research & Development, S.N.C. (FR) | 2001-03-28 | — | — | EP | claimed |
| WO-1999065872-A1 | DIARYLSELENIDE COMPOUNDS AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETICS | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 1999-12-23 | — | — | WO | claimed |
| EP-1086080-B1 | DIARYLSELENIDE COMPOUNDS AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETICS | GALDERMA RES & DEV (FR) | 2004-08-25 | — | — | EP | disclosed |
| EP-1086080-A1 | DIARYLSELENIDE COMPOUNDS AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETICS | Galderma Research & Development, S.N.C. (FR) | 2001-03-28 | — | — | EP | disclosed |
| WO-1999065872-A1 | DIARYLSELENIDE COMPOUNDS AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETICS | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 1999-12-23 | — | — | WO | disclosed |